Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Orphan Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Biopharmaceutical Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Orphan Drugs include Amber Specialty Pharmacy, Alexion Pharmaceuticals (Astra AB), Johnson & Johnson, Novartis, Celgene (Bristol-Myers Squibb), AbbVie, GSK, Roche and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Orphan drugs are medicines that are used to treat diseases that cannot be produced profitably without the assistance of the government because there are so few patients. Conditions that are treated are known as rare diseases.
This report aims to provide a comprehensive presentation of the global market for Orphan Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orphan Drugs. This report contains market size and forecasts of Orphan Drugs in global, including the following market information:
Global Orphan Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Orphan Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Orphan Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Orphan Drugs Market Segment Percentages, by Type, 2022 (%)
Biopharmaceutical
Other
Global Orphan Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Orphan Drugs Market Segment Percentages, by Application, 2022 (%)
Child
Aldult
Global Orphan Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Orphan Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Orphan Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Orphan Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amber Specialty Pharmacy
Alexion Pharmaceuticals (Astra AB)
Johnson & Johnson
Novartis
Celgene (Bristol-Myers Squibb)
AbbVie
GSK
Roche
Sanofi
Pfizer
Vertex
Merck & Co.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Orphan Drugs, market overview.
Chapter 2: Global Orphan Drugs market size in revenue.
Chapter 3: Detailed analysis of Orphan Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Orphan Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Orphan Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Orphan Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Orphan Drugs Overall Market Size
2.1 Global Orphan Drugs Market Size: 2022 VS 2029
2.2 Global Orphan Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Orphan Drugs Players in Global Market
3.2 Top Global Orphan Drugs Companies Ranked by Revenue
3.3 Global Orphan Drugs Revenue by Companies
3.4 Top 3 and Top 5 Orphan Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Orphan Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Orphan Drugs Players in Global Market
3.6.1 List of Global Tier 1 Orphan Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Orphan Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Orphan Drugs Market Size Markets, 2022 & 2029
4.1.2 Biopharmaceutical
4.1.3 Other
4.2 By Type - Global Orphan Drugs Revenue & Forecasts
4.2.1 By Type - Global Orphan Drugs Revenue, 2018-2023
4.2.2 By Type - Global Orphan Drugs Revenue, 2024-2029
4.2.3 By Type - Global Orphan Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Orphan Drugs Market Size, 2022 & 2029
5.1.2 Child
5.1.3 Aldult
5.2 By Application - Global Orphan Drugs Revenue & Forecasts
5.2.1 By Application - Global Orphan Drugs Revenue, 2018-2023
5.2.2 By Application - Global Orphan Drugs Revenue, 2024-2029
5.2.3 By Application - Global Orphan Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Orphan Drugs Market Size, 2022 & 2029
6.2 By Region - Global Orphan Drugs Revenue & Forecasts
6.2.1 By Region - Global Orphan Drugs Revenue, 2018-2023
6.2.2 By Region - Global Orphan Drugs Revenue, 2024-2029
6.2.3 By Region - Global Orphan Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Orphan Drugs Revenue, 2018-2029
6.3.2 US Orphan Drugs Market Size, 2018-2029
6.3.3 Canada Orphan Drugs Market Size, 2018-2029
6.3.4 Mexico Orphan Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Orphan Drugs Revenue, 2018-2029
6.4.2 Germany Orphan Drugs Market Size, 2018-2029
6.4.3 France Orphan Drugs Market Size, 2018-2029
6.4.4 U.K. Orphan Drugs Market Size, 2018-2029
6.4.5 Italy Orphan Drugs Market Size, 2018-2029
6.4.6 Russia Orphan Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Orphan Drugs Market Size, 2018-2029
6.4.8 Benelux Orphan Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Orphan Drugs Revenue, 2018-2029
6.5.2 China Orphan Drugs Market Size, 2018-2029
6.5.3 Japan Orphan Drugs Market Size, 2018-2029
6.5.4 South Korea Orphan Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Orphan Drugs Market Size, 2018-2029
6.5.6 India Orphan Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Orphan Drugs Revenue, 2018-2029
6.6.2 Brazil Orphan Drugs Market Size, 2018-2029
6.6.3 Argentina Orphan Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Orphan Drugs Revenue, 2018-2029
6.7.2 Turkey Orphan Drugs Market Size, 2018-2029
6.7.3 Israel Orphan Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Orphan Drugs Market Size, 2018-2029
6.7.5 UAE Orphan Drugs Market Size, 2018-2029
7 Orphan Drugs Companies Profiles
7.1 Amber Specialty Pharmacy
7.1.1 Amber Specialty Pharmacy Company Summary
7.1.2 Amber Specialty Pharmacy Business Overview
7.1.3 Amber Specialty Pharmacy Orphan Drugs Major Product Offerings
7.1.4 Amber Specialty Pharmacy Orphan Drugs Revenue in Global Market (2018-2023)
7.1.5 Amber Specialty Pharmacy Key News & Latest Developments
7.2 Alexion Pharmaceuticals (Astra AB)
7.2.1 Alexion Pharmaceuticals (Astra AB) Company Summary
7.2.2 Alexion Pharmaceuticals (Astra AB) Business Overview
7.2.3 Alexion Pharmaceuticals (Astra AB) Orphan Drugs Major Product Offerings
7.2.4 Alexion Pharmaceuticals (Astra AB) Orphan Drugs Revenue in Global Market (2018-2023)
7.2.5 Alexion Pharmaceuticals (Astra AB) Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Orphan Drugs Major Product Offerings
7.3.4 Johnson & Johnson Orphan Drugs Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Orphan Drugs Major Product Offerings
7.4.4 Novartis Orphan Drugs Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Celgene (Bristol-Myers Squibb)
7.5.1 Celgene (Bristol-Myers Squibb) Company Summary
7.5.2 Celgene (Bristol-Myers Squibb) Business Overview
7.5.3 Celgene (Bristol-Myers Squibb) Orphan Drugs Major Product Offerings
7.5.4 Celgene (Bristol-Myers Squibb) Orphan Drugs Revenue in Global Market (2018-2023)
7.5.5 Celgene (Bristol-Myers Squibb) Key News & Latest Developments
7.6 AbbVie
7.6.1 AbbVie Company Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Orphan Drugs Major Product Offerings
7.6.4 AbbVie Orphan Drugs Revenue in Global Market (2018-2023)
7.6.5 AbbVie Key News & Latest Developments
7.7 GSK
7.7.1 GSK Company Summary
7.7.2 GSK Business Overview
7.7.3 GSK Orphan Drugs Major Product Offerings
7.7.4 GSK Orphan Drugs Revenue in Global Market (2018-2023)
7.7.5 GSK Key News & Latest Developments
7.8 Roche
7.8.1 Roche Company Summary
7.8.2 Roche Business Overview
7.8.3 Roche Orphan Drugs Major Product Offerings
7.8.4 Roche Orphan Drugs Revenue in Global Market (2018-2023)
7.8.5 Roche Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Orphan Drugs Major Product Offerings
7.9.4 Sanofi Orphan Drugs Revenue in Global Market (2018-2023)
7.9.5 Sanofi Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Orphan Drugs Major Product Offerings
7.10.4 Pfizer Orphan Drugs Revenue in Global Market (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 Vertex
7.11.1 Vertex Company Summary
7.11.2 Vertex Business Overview
7.11.3 Vertex Orphan Drugs Major Product Offerings
7.11.4 Vertex Orphan Drugs Revenue in Global Market (2018-2023)
7.11.5 Vertex Key News & Latest Developments
7.12 Merck & Co.
7.12.1 Merck & Co. Company Summary
7.12.2 Merck & Co. Business Overview
7.12.3 Merck & Co. Orphan Drugs Major Product Offerings
7.12.4 Merck & Co. Orphan Drugs Revenue in Global Market (2018-2023)
7.12.5 Merck & Co. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
